Results 51 to 60 of about 34,818 (215)

Nanobodies as next‐generation targeting platforms: From discovery technologies to translational biomedicine

open access: yesVIEW, EarlyView.
Nanobodies, derived from the variable domains of camelid heavy‐chain‐only antibodies, have emerged as transformative biomedical tools due to their nanoscale size, exceptional stability, and unique capacity to recognize cryptic epitopes. This review provides a comprehensive overview of the field, outlining the structural and biochemical features of ...
Zhenrui Ye, Xianyang Li, Meixiao Zhan
wiley   +1 more source

Methods for ascertaining norovirus disease burdens

open access: yesHuman Vaccines & Immunotherapeutics, 2017
Norovirus is the commonest cause of gastrointestinal disease worldwide in. Infections with norovirus occur in all age groups, however, the highest incidence is in children aged less than five years.
David J. Allen, John P. Harris
doaj   +1 more source

Norovirus GII.4 antibodies in the Portuguese population

open access: yesJournal of Infection in Developing Countries, 2014
Introduction: Norovirus GII.4 is the leading cause of outbreaks of acute and sporadic acute gastroenteritis worldwide. Information on the prevalence of norovirus in Portugal is scarce or null.
João Rodrigo Mesquita   +1 more
doaj   +1 more source

Risk factors for norovirus infection in healthcare workers during nosocomial outbreaks: a cross-sectional study

open access: yesAntimicrobial Resistance and Infection Control, 2021
Background Norovirus outbreaks cause severe medico-socio-economic problems affecting healthcare workers and patients. The aim of the study was to investigate prevalence of norovirus infection and risk factors for infection in healthcare workers during ...
Kjell Torén   +7 more
doaj   +1 more source

When to consider an inborn error of immunity: clues for physicians

open access: yesInternal Medicine Journal, EarlyView.
Abstract The term inborn errors of immunity (IEIs) refers to the rapidly expanding group of genetic disorders causing dysregulation of the immune system. With improved genetic testing in recent years, the number of defined IEIs and their range of phenotypic presentations has grown vastly, with more than 550 IEIs now described.
Meera Thangarajah, Lucinda J. Berglund
wiley   +1 more source

Bridging the Gap Between General and Transplant Infectious Disease Practice

open access: yesTransplant Infectious Disease, EarlyView.
ABSTRACT The population of iatrogenic immunocompromised individuals is steadily rising as we continue to improve in our ability to manage diseases, including cancer, autoimmune disease, and end‐organ dysfunction, with increasing access to novel agents and transplantation.
Jeremey Walker   +4 more
wiley   +1 more source

Norovirus-attributable encounters by season and population.

open access: yes, 2016
Norovirus-attributable encounters by season and population.
Ashley N. Alcala (2552548)   +4 more
core   +1 more source

Genetic recombination and genotype diversity of norovirus GI in children with acute gastroenteritis in Thailand, 2015-2021

open access: yesJournal of Infection and Public Health
Background: Human norovirus is a predominant etiological agent responsible for acute gastroenteritis across all age groups. Recently, norovirus recombinant strains have been reported as the cause of norovirus outbreaks in several settings and the strains
Pattara Khamrin   +7 more
doaj   +1 more source

Specific Interactions between Human Norovirus and Environmental Matrices: Effects on the Virus Ecology

open access: yesViruses, 2019
Human norovirus is the major cause of non-bacterial epidemic gastroenteritis. Human norovirus binds to environmental solids via specific and non-specific interactions, and several specific receptors for human norovirus have been reported.
Mohan Amarasiri, Daisuke Sano
doaj   +1 more source

Life Course Malaria Exposure and SARS‐CoV‐2 Seroepidemiology in Ugandan Adolescents: A Longitudinal Study Nested in a Birth Cohort

open access: yesTropical Medicine &International Health, EarlyView.
ABSTRACT Background COVID‐19 has had major global health impacts, yet reported morbidity and mortality have been lower in Africa despite serological evidence of widespread infection. Malaria has been proposed as a potential modifier of susceptibility to and outcomes of SARS‐CoV‐2 infection.
Ludoviko Zirimenya   +22 more
wiley   +1 more source

Home - About - Disclaimer - Privacy